PH15145A - Antihypercholesteraemic agent,monacolin k.process for the production and compositions containing same - Google Patents

Antihypercholesteraemic agent,monacolin k.process for the production and compositions containing same

Info

Publication number
PH15145A
PH15145A PH23668A PH23668A PH15145A PH 15145 A PH15145 A PH 15145A PH 23668 A PH23668 A PH 23668A PH 23668 A PH23668 A PH 23668A PH 15145 A PH15145 A PH 15145A
Authority
PH
Philippines
Prior art keywords
antihypercholesteraemic
monacolin
agent
production
compositions containing
Prior art date
Application number
PH23668A
Other languages
English (en)
Inventor
Endo Akira
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of PH15145A publication Critical patent/PH15145A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30—Oxygen atoms, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/145—Fungal isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02—Oxygen as only ring hetero atoms
    • C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/645—Fungi ; Processes using fungi

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Obesity (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PH23668A 1979-02-20 1980-02-20 Antihypercholesteraemic agent,monacolin k.process for the production and compositions containing same PH15145A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP54017856A JPS5925599B2 (ja) 1979-02-20 1979-02-20 新生理活性物質モナコリンｋおよびその製造法

Publications (1)

Publication Number Publication Date
PH15145A true PH15145A (en) 1982-08-24

Family

ID=11955290

Family Applications (1)

Application Number Title Priority Date Filing Date
PH23668A PH15145A (en) 1979-02-20 1980-02-20 Antihypercholesteraemic agent,monacolin k.process for the production and compositions containing same

Country Status (27)

Country Link
JP (1) JPS5925599B2 (fr)
KR (1) KR830002801B1 (fr)
AT (1) AT373915B (fr)
AU (1) AU532626B2 (fr)
BE (1) BE881825A (fr)
CA (1) CA1129794A (fr)
CH (1) CH645890A5 (fr)
DD (1) DD154494A5 (fr)
DE (2) DE3051175C2 (fr)
DK (2) DK149095C (fr)
ES (1) ES8103171A1 (fr)
FI (1) FI66427C (fr)
FR (1) FR2449685B1 (fr)
GB (1) GB2046737B (fr)
HU (1) HU182069B (fr)
IE (1) IE49743B1 (fr)
IT (1) IT1175260B (fr)
MX (1) MX6314E (fr)
NL (1) NL191540C (fr)
NO (1) NO153974C (fr)
NZ (1) NZ192919A (fr)
PH (1) PH15145A (fr)
PL (1) PL124304B1 (fr)
SE (1) SE453301B (fr)
SG (1) SG6784G (fr)
SU (2) SU1158048A3 (fr)
ZA (1) ZA80962B (fr)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55150898A (en) * 1979-05-11 1980-11-25 Sankyo Co Ltd Preparation of a new physiologically active substance mb-530b
US4231938A (en) * 1979-06-15 1980-11-04 Merck & Co., Inc. Hypocholesteremic fermentation products and process of preparation
JPS5621594A (en) * 1979-07-27 1981-02-28 Sankyo Co Ltd Mb-530b carboxylic acid metal salt and its preparation
PT72394B (en) * 1980-02-04 1982-09-06 Merck & Co Inc Process for preparing dihydro and tetrahydromevinoline hypocholesterolimics
AU548996B2 (en) * 1980-02-04 1986-01-09 Merck & Co., Inc. Tetrahydro-2h-pyran-2-one derivatives
JPH0692381B2 (ja) * 1980-03-31 1994-11-16 三共株式会社 Ｍｂ−５３０ａ誘導体
JPS56142236A (en) 1980-04-08 1981-11-06 Sankyo Co Ltd Ml-236a and mb-530a derivative
DK149080C (da) * 1980-06-06 1986-07-28 Sankyo Co Fremgangsmaade til fremstilling af derivater af ml-236b-carboxylsyre
JPS5835144A (ja) * 1981-08-27 1983-03-01 Sankyo Co Ltd Ｍｂ−５３０ｂ誘導体およびその製造法
US4782084A (en) * 1987-06-29 1988-11-01 Merck & Co., Inc. HMG-COA reductase inhibitors
US4997848A (en) * 1987-10-27 1991-03-05 Sankyo Company, Limited Octahydronaphthalene oxime derivatives for cholesterol synthesis inhibition
CA2062023A1 (fr) * 1992-02-10 1993-08-11 Jagroop S. Dahiya Nouvelles souches fongiques et leur utilisation pour la production d'antibiotiques
JPH07504568A (ja) * 1992-03-04 1995-05-25 藤沢薬品工業株式会社 ＨＭＧ−ＣｏＡレダクターゼ阻害物質としてのテトラリン誘導体
NZ247617A (en) 1992-05-15 1995-07-26 Sankyo Co Octahydronaphthalene oxime derivatives and pharmaceutical compositions
US6812007B1 (en) * 1992-11-04 2004-11-02 Keri Vilmos Process for the isolation and purification of mevinolin
HU210867B (en) * 1992-11-04 1995-10-30 Biogal Gyogyszergyar Method for extraction and purification of mevinolin from culture medium
SI9300303A (en) * 1993-06-08 1994-12-31 Krka Tovarna Zdravil Process for isolation of hypolipemic effective substance
US5409820A (en) * 1993-08-06 1995-04-25 Apotex, Inc. Process for the production of lovastatin using Coniothyrium fuckelii
US6046022A (en) 1996-09-30 2000-04-04 Peking University Methods and compositions employing red rice fermentation products
US7238348B2 (en) 1996-09-30 2007-07-03 Beijing Peking University Wbl Corporation Ltd. Method of treatment of osteoporosis with compositions of red rice fermentation products
NZ500870A (en) 1998-03-20 2002-03-01 Biogal Gyogyszergyar Metabolic controlled fermentation process for preparing mevinolin (lovastatin)
AU3654301A (en) 2000-02-24 2001-09-03 Biogal Gyogyszergyar Method of purifying a fermentation broth
HUP0301214A2 (hu) 2000-03-03 2003-08-28 Plus Chemicals S.A. Tisztítási eljárás csökkentett dimer szennyező tartalmú lovastatin és simvastatin előállítására
KR20010095780A (ko) * 2000-04-12 2001-11-07 나가오카 마사시 배아 홍국
IN192861B (fr) 2000-06-30 2004-05-22 Ranbaxy Lab Ltd
WO2002064809A2 (fr) * 2001-02-09 2002-08-22 Unilever N.V. Methode de preparation d'une ou plusieurs statines par fermentation
KR100379075B1 (en) 2002-03-07 2003-04-08 Jinis Biopharmaceuticals Co Method for producing low cholesterol animal food product and food product therefrom
KR20020093147A (ko) * 2002-05-30 2002-12-13 지니스생명공학 주식회사 성인병 예방 및 치료 보조제
KR100710500B1 (ko) 2005-05-18 2007-04-24 고려대학교 산학협력단 홍국균을 이용한 모나콜린 ｋ 생산방법
EP2373609B1 (fr) 2008-12-19 2013-10-16 KRKA, D.D., Novo Mesto Utilisation de composés amphiphiles pour la cristallisation régulée de statines et d'intermédiaires de statines
EP2327682A1 (fr) 2009-10-29 2011-06-01 KRKA, D.D., Novo Mesto Utilisation de composés amphiphiles pour la crystallisation controlée de statines et d'intermediaires de statines.
RO128803A0 (ro) 2012-10-12 2013-09-30 Ion Gigel Fulga Compoziţie pentru tratamentul sau prevenirea dislipidemiilor
CN110331151A (zh) * 2019-04-11 2019-10-15 北京工商大学 紫色红曲菌mokH基因过表达菌株的构建方法
CN111297938A (zh) * 2020-03-11 2020-06-19 北京康立生医药技术开发有限公司 一种辅助降血脂组合物中洛伐他汀的检测方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5612114B2 (fr) * 1974-06-07 1981-03-18
JPS55150898A (en) * 1979-05-11 1980-11-25 Sankyo Co Ltd Preparation of a new physiologically active substance mb-530b
AU535944B2 (en) * 1979-06-15 1984-04-12 Merck & Co., Inc. Hypocholestermic fermentation products from aspergillus

Also Published As

Publication number Publication date
SE453301B (sv) 1988-01-25
DE3051175C2 (fr) 1989-12-21
IT8067262A0 (it) 1980-02-20
NZ192919A (en) 1984-07-06
GB2046737B (en) 1983-01-12
ZA80962B (en) 1981-03-25
KR830002801B1 (ko) 1983-12-16
HU182069B (en) 1983-12-28
SG6784G (en) 1985-02-08
NO153974C (no) 1986-06-25
SU1158048A3 (ru) 1985-05-23
SE8001339L (sv) 1980-08-21
NO153974B (no) 1986-03-17
AT373915B (de) 1984-03-12
DD154494A5 (de) 1982-03-24
BE881825A (fr) 1980-08-20
DE3006216A1 (de) 1980-09-04
JPS5925599B2 (ja) 1984-06-19
ES488796A0 (es) 1981-02-16
FI800506A (fi) 1980-08-21
MX6314E (es) 1985-04-01
JPS55111790A (en) 1980-08-28
PL124304B1 (en) 1983-01-31
DE3006216C2 (de) 1985-10-31
DK73080A (da) 1980-08-21
FI66427C (fi) 1984-10-10
FR2449685A1 (fr) 1980-09-19
AU5567380A (en) 1980-08-28
FR2449685B1 (fr) 1985-06-28
CH645890A5 (de) 1984-10-31
IT1175260B (it) 1987-07-01
FI66427B (fi) 1984-06-29
PL222120A1 (fr) 1980-10-20
DK149095C (da) 1986-06-16
AU532626B2 (en) 1983-10-06
DK149095B (da) 1986-01-20
ATA92980A (de) 1983-07-15
DK21889A (da) 1989-01-18
SU969702A1 (ru) 1982-10-30
CA1129794A (fr) 1982-08-17
DK21889D0 (da) 1989-01-18
GB2046737A (en) 1980-11-19
NL191540C (nl) 1995-09-04
NL191540B (nl) 1995-05-01
ES8103171A1 (es) 1981-02-16
KR830002030A (ko) 1983-05-21
NL8001041A (nl) 1980-08-22
NO800451L (no) 1980-08-21
IE800321L (en) 1980-08-20
IE49743B1 (en) 1985-12-11

Similar Documents

Publication Publication Date Title
PH15145A (en) Antihypercholesteraemic agent,monacolin k.process for the production and compositions containing same
DE3062187D1 (en) Cleaning composition, process for its production and its use
CA1033750A (fr) Derives de methyl-5 isoflavone, synthese et composes obtenus
PT73388B (en) Process for preparing antiinflammatory 4,5-diaryl-alfa-poly- fluoroalkyl-1h-imidazole-2-methanamides and pharmaceutical compositions containing the same
DE3066702D1 (en) 2.5-diketopiperazine-derivative, process for its preparation and its use
GB2019837A (en) N-Oxacyclic-alkylpiperidyl-diazacompounds, process for their manufacture and pharmaceutical compositions containing them
PT65016A (en) Process for the preparation of 1-(3,3,3-triarylpropyl)-4-phenyl-4-piperidinemethanols
AU542902B2 (en) Substituted carboxylic ceto-acids, process for the preparation thereof, use thereof and medicinal compositions containing them
DE3167664D1 (en) Pyrazoloindazole derivatives, process for preparing the same, and pharmaceutical composition containing the same
DE3063315D1 (en) Process for the production of 2,6-dialkylcyclohexylamines
ZA786054B (en) Novel 6-oxy-genated-3,20-dioxo-pregnane-derivatives,process for the preparation thereof,and pharmaceutical compositions containing them
DE3060259D1 (en) Diphenyl ether derivatives, process for preparing the same and herbicidal compositions containing the same
PT66891A (en) Process for the preparation of 1,5 disubstituted-2-pyrrolidones
DE3168442D1 (en) Tetrazolylcoumarin derivatives, process for preparing the same and composition containing the same
IL52148A (en) Substituted 1-phenoxy-2-hydroxy-3-aminopropanes,process for preparing same and pharmaceutical compositions containing them
ZA807283B (en) Nicotinamide derivative,process for preparing the same and pharmaceutical composition containing the same
DE3164568D1 (en) Kijanimicin, pharmaceutical compositions containing it and processes for preparing kijanimicin and the compositions
IL59608A0 (en) New 2-phenyl-4-pyrone derivatives,processes for their preparation and fungicidal compositions containing the same
DE3067981D1 (en) Substituted norbornanone acetals, process for preparing the same, and perfume compositions containing the same
PT65256B (en) Process for the preparation of 1-acyl-1,2,3,4-tetrahydro-6-quinolinols.
ZA785509B (en) Novel thiopropionamides,the processes for making them and the pharmaceutical compositions
EP0054570A4 (fr) Nouveaux glycosides de condurango, procede de preparation de ceux-ci, agents antineoplastes, et composition contenant ces composes.
DE2960069D1 (en) Process for the manufacture of n,n-dimethylaminoacetonitrile
ZA794173B (en) Basically substituted urea compounds,process for producing the same and pharmaceutical compositions containing the same
PH15051A (en) Pyrimidine derivative,process for the preparation and compositions containing same